in vivo delivery from study to gene therapy: overview, considerations and challenges

Register & watch

Tuesday, June 18, 2019
18:00 to 19:00 CEST (Berlin, Paris, Madrid)

in vivo transfection is a non-viral method to deliver nucleic acids directly into an animal or in Human.

This technique can be used for in vivo proof of concept studies up to Gene Therapy. To successfully deliver nucleic acids into a specific organ, it is important to understand how in vivo transfection can be performed and what the limitations of this technique are. As delivery experts, Polyplus-transfection gives an overview of the in vivo delivery methods and delves into key considerations and challenges that come with in vivo experimentation.

With this webinar, you will acquire an understanding of:

  • in vivo delivery methods to generate an animal model
  • key parameters to consider when choosing an approach
  • how to address in vivo delivery challenges

Register & watch

Presented by:

Alengo Nyamay'antu, PhD

Alengo Nyamay’antu is Scientific Support and Communication Specialist at Polyplus-transfection® SA, a leading biotechnology company that provides solutions for delivery of nucleic acids in research, bioproduction and therapeutics. Alengo completed her MSc in structural and functional biochemistry at the University of Lyon and went on to specialise in protein biochemistry at the University of Manchester. She then continued to develop and widen her scientific and communication skills by joining the Max Planck Institute for Biomedicine as a postdoctoral researcher. Alengo is particularly keen on exchanging and discussing science, and looks forward to the upcoming webinar to get you started on genome editing with the latest technologies.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.